Metastatic Hormone-Sensitive Prostate Cancer
Conditions
Keywords
mHSPC, Urological cancers
Brief summary
The purpose of this study is to establish an expert consensus recommendations on managing patients with mHSPC in South Korea, and to provide clinicians with a comprehensive guide to support their clinical decision making. There are no secondary objectives for this study.
Detailed description
Data collection for this study will be conducted through 2 rounds of web-based surveys of health care professionals (HCPs). A meeting with the panelists will be held as a 3rd round if a consensus for pre determined key questions is not achieved after the 2 rounds of the survey.
Interventions
OTHERNo Intervention
No investigational drug will be administered to participants in this study.
Sponsors
Astellas Pharma Korea, Inc.
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Urologist from university hospitals in South Korea. * Has a minimum 10 years of practice experience (experience as a military or public health doctor could be considered practice experience) * Sees a minimum of 50 mHSPC patients in a year. * At least 10 publications in SCIE (Science Citation Index Expanded) journals in the past 5 years.
Exclusion criteria
* Urologist in private practice.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Treatment plans for patients with mHSPC | Up to 7 days | Treatment plans for patients with mHSPC within the local healthcare environment will be collected via online surveys and a consensus meeting will be held if required. |
Countries
South Korea
Outcome results
None listed